Saba Capital Management, L.P. bought HQL
May 2, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 26,274 shares of Abrdn Life Sciences Investors at $13.46 per share, a transaction worth $353.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
26,274
Price
$13.46
Total value
$353.6K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 2, 2024
Filing dateMay 2, 2024
Shares owned after3,068,730
OwnershipIndirect
10b5-1 planNo
AmendedNo